Drugplain

Xpect Triple Antibiotic 400 [iU]/g

bacitracin zinc, neomycin sulfate, polymyxin b sulfate · OINTMENT · Cintas Corporation

No Recall History
Plain English

Xpect Triple Antibiotic is a ointment containing bacitracin zinc, neomycin sulfate, polymyxin b sulfate at 400 [iU]/g, taken topical. Manufactured by Cintas Corporation.

Key Facts

Brand Name
Xpect Triple Antibiotic
Generic Name
bacitracin zinc, neomycin sulfate, polymyxin b sulfate
NDC Code (Product)
42961-236
Manufacturer
Cintas Corporation
Strength
400 [iU]/g
Dosage Form
OINTMENT
Route
TOPICAL
Marketing Status
Application #
M004
Marketing Start
09/13/2023

Recall History

No Recall History

Frequently Asked Questions

What is Xpect Triple Antibiotic used for?

Xpect Triple Antibiotic contains bacitracin zinc, neomycin sulfate, polymyxin b sulfate. It is a ointment taken topical. Consult your doctor for specific uses.

Is Xpect Triple Antibiotic a controlled substance?

Xpect Triple Antibiotic is not classified as a controlled substance by the DEA.

What is the generic name for Xpect Triple Antibiotic?

The generic name for Xpect Triple Antibiotic is bacitracin zinc, neomycin sulfate, polymyxin b sulfate. There are 12 other brand versions of bacitracin zinc, neomycin sulfate, polymyxin b sulfate.

What is the NDC code for Xpect Triple Antibiotic 400 [iU]/g?

The NDC (National Drug Code) for Xpect Triple Antibiotic 400 [iU]/g is 42961-236, listed by Cintas Corporation.